Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Alpha Cognition Inc. (ACOG : NSDQ)

• Company Description    Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia. Number of Employees: 71

• Price / Volume Information    Yesterday's Closing Price: $7.90 Daily Weekly Monthly 20 Day Moving Average: 94,027 shares Shares Outstanding: 21.77 (millions) Market Capitalization: $172.01 (millions) Beta: 2.32 52 Week High: $10.15 52 Week Low: $4.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 21.54% 20.64% 12 Week 32.33% 28.71% Year To Date 21.54% 17.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1452 Hughes Rd. Ste. 200 - Grapevine,TX 76051 CAN ph: 858-344-4375 fax: - ir@alphacognition.com http://www.alphacognition.com

• General Corporate Information    Officers Michael McFadden - Chief Executive Officer and Director Henry Du - Vice President of Finance and Accounting and inter Len Mertz - Director Kenneth Cawkell - Director Robert Wills - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 02074J501 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 21.77 Most Recent Split Date: 11.00 (0.04:1) Beta: 2.32 Market Capitalization: $172.01 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.32 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.37 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.99 Price/Cash Flow: - Price / Sales: 15.89 EPS Growth vs. Year Ago Period: -85.00% vs. Previous Quarter: -23.33% Sales Growth vs. Year Ago Period: 20.66% vs. Previous Quarter: 26.53% ROE 06/30/26 - - 03/31/26 - -58.35 12/31/25 - -55.71 ROA 06/30/26 - - 03/31/26 - -45.99 12/31/25 - -43.78 Current Ratio 06/30/26 - - 03/31/26 - 12.64 12/31/25 - 8.65 Quick Ratio 06/30/26 - - 03/31/26 - 11.52 12/31/25 - 8.09 Operating Margin 06/30/26 - - 03/31/26 - -276.49 12/31/25 - -249.35 Net Margin 06/30/26 - - 03/31/26 - -232.23 12/31/25 - -202.23 Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - -202.25 Book Value 06/30/26 - - 03/31/26 - 2.64 12/31/25 - 2.88 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - 0.55 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©